van der Valk M - Search Results

1

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Jonkers J, et al. Among authors: van der valk m, van der gulden h. Nat Genet. 2001 Dec;29(4):418-25. doi: 10.1038/ng747. Nat Genet. 2001. PMID: 11694875 Free article.

2

Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.

Vooijs M, te Riele H, van der Valk M, Berns A. Vooijs M, et al. Among authors: van der valk m. Oncogene. 2002 Jul 11;21(30):4635-45. doi: 10.1038/sj.onc.1205575. Oncogene. 2002. PMID: 12096340

3

p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.

Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A. Krimpenfort P, et al. Among authors: van der valk m. Nature. 2007 Aug 23;448(7156):943-6. doi: 10.1038/nature06084. Nature. 2007. PMID: 17713536

4

A conditional mouse model for malignant mesothelioma.

Jongsma J, van Montfort E, Vooijs M, Zevenhoven J, Krimpenfort P, van der Valk M, van de Vijver M, Berns A. Jongsma J, et al. Among authors: van montfort e, van der valk m, van de vijver m. Cancer Cell. 2008 Mar;13(3):261-71. doi: 10.1016/j.ccr.2008.01.030. Cancer Cell. 2008. PMID: 18328429 Free article.

5

p107 is a suppressor of retinoblastoma development in pRb-deficient mice.

Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H. Robanus-Maandag E, et al. Among authors: van der valk m. Genes Dev. 1998 Jun 1;12(11):1599-609. doi: 10.1101/gad.12.11.1599. Genes Dev. 1998. PMID: 9620848 Free PMC article.

6

Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.

Vooijs M, van der Valk M, te Riele H, Berns A. Vooijs M, et al. Among authors: van der valk m. Oncogene. 1998 Jul 9;17(1):1-12. doi: 10.1038/sj.onc.1202169. Oncogene. 1998. PMID: 9671308

7

In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3.

Jonkers J, van Amerongen R, van der Valk M, Robanus-Maandag E, Molenaar M, Destrée O, Berns A. Jonkers J, et al. Among authors: van amerongen r, van der valk m. Mech Dev. 1999 Nov;88(2):183-94. doi: 10.1016/s0925-4773(99)00187-2. Mech Dev. 1999. PMID: 10534617 Free article.

8

Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.

Jonkers J, Weening JJ, van der Valk M, Bobeldijk R, Berns A. Jonkers J, et al. Among authors: van der valk m. Oncogene. 1999 Oct 28;18(44):5982-90. doi: 10.1038/sj.onc.1202995. Oncogene. 1999. PMID: 10557087

9

Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.

Meuwissen R, Linn SC, van der Valk M, Mooi WJ, Berns A. Meuwissen R, et al. Among authors: van der valk m. Oncogene. 2001 Oct 4;20(45):6551-8. doi: 10.1038/sj.onc.1204837. Oncogene. 2001. PMID: 11641780

10

Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin.

Robanus-Maandag E, Giovannini M, van der Valk M, Niwa-Kawakita M, Abramowski V, Antonescu C, Thomas G, Berns A. Robanus-Maandag E, et al. Among authors: van der valk m. Oncogene. 2004 Aug 26;23(39):6541-7. doi: 10.1038/sj.onc.1207858. Oncogene. 2004. PMID: 15221010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page